Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index

S. Korn (Mainz, Germany), W. Busse (Madison, United States of America), J. Echave-Sustaeta (Madrid, Spain), A. Dixon (Burlington, United States of America), J. Mucsi (Gödöllö, Hungary), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), N. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)

Source: International Congress 2019 – Clinical aspects of airway diseases
Session: Clinical aspects of airway diseases
Session type: Thematic Poster
Number: 2753
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Korn (Mainz, Germany), W. Busse (Madison, United States of America), J. Echave-Sustaeta (Madrid, Spain), A. Dixon (Burlington, United States of America), J. Mucsi (Gödöllö, Hungary), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), N. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America). Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index. 2753

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: